2034 Acute Reduction of Lipoprotein ( a ) by Tissue - Type Plasminogen Activator

نویسندگان

  • Robert A. Hegele
  • Michael R. Freeman
  • Anatoly Langer
  • Philip W. Connelly
چکیده

Background. Lipoprotein(a) [Lp(a)] is a low density lipoprotein-like particle whose apolipoprotein B (apo B) moiety is disulfide-linked to apo(a), a plasminogen-like inhibitor of fibrinolysis in vitro. We hypothesized that plasma concentrations of Lp(a) are acutely affected by intravenous tissue-type plasminogen activator (t-PA). Methods and Results. Patients with unstable angina were randomized to receive either intravenous t-PA (n= 15) or placebo (n =11). Two-way ANOVA using repeated measures revealed a significant effect of t-PA

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.

BACKGROUND Lipoprotein(a) [Lp(a)] is a low density lipoprotein-like particle whose apolipoprotein B (apo B) moiety is disulfide-linked to apo(a), a plasminogen-like inhibitor of fibrinolysis in vitro. We hypothesized that plasma concentrations of Lp(a) are acutely affected by intravenous tissue-type plasminogen activator (t-PA). METHODS AND RESULTS Patients with unstable angina were randomize...

متن کامل

Optimizing refolding condition for recombinant tissue plasminogen activator

Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...

متن کامل

The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...

متن کامل

Lipoprotein(a) as a Biomarker for Risk Stratification of Acute Myocardial Infarction

AMI: Acute Myocardial Infarction; aPTT, Activated Partial Thromboplastin Time; CCSP: Clinical Coronary Stenosis Progression; CK: Creatine Kinase; CRP: C-reactive Protein; CVD: Cerebrovascular Disease; CVP: Cerebral Vasculopathies; HDL: High Density Lipoprotein; LDL: Low Density Lipoprotein; Lp(a): Lipoprotein (a); MACE: Major Adverse Cardiac Event; PAI-1: Plasminogen Activator Inhibitor-1; PT: ...

متن کامل

A clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors

Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005